Since May, a rare and vaccine-resistant strain of Ebola called Bundibugyo has claimed more than 2,060 lives across the Democratic Republic of Congo and Uganda, becoming the second-deadliest outbreak of the virus in recorded history. The World Health Organisation warns that the epidemic is accelerating faster than any before it, outpacing the systems designed to contain it. With no approved vaccine and early symptoms mistaken for common illness, humanity finds itself once again in a familiar and humbling position — running to catch up with nature's indifference.
The daily Star
· Aug 13, 2026
· health
· 2 min read
High
Sourcing: Verified
WHO warns rare Ebola strain could become deadliest ever as 2,000 die
Over 2,060 deaths confirmed across 4,500 cases in Democratic Republic of Congo and Uganda since May outbreak declaration.
◉
Health & Medicine
8252 related articles
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 100% match
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight-Loss Treatment
Interesting Engineering · 99% match
Eli Lilly's Oral GLP-1 Pill Shows Promise for Diabetes and Weight Loss
TODAY · 99% match
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight Loss Drug
ScienceAlert · 99% match
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 99% match
Related Coverage
World Socialist Web Site · Aug 22
H5N1 avian flu spreads across Australia with 290 confirmed infections
Australia faces a rapidly spreading H5N1 avian flu outbreak with 290 confirmed infections across all states, threatening…
Devdiscourse · Aug 22 Congo's Bundibugyo Crisis: Health Attacks Threaten Economic Stability Beyond Medical ResponseWHO warns that violence and attacks on health facilities in eastern DRC's Bundibugyo outbreak threaten disease control a…
The Times of India · Aug 22 Reactor blast at Telangana pharma unit kills 2, injures 9A reactor blast at a pharmaceutical unit in Telangana's Yadadri Bhuvanagiri district killed two workers and injured nine…
Google News · Aug 22 Exercise-mimicking weight-loss pill clears first human trialsEnveda's ENV-308, a novel obesity drug designed to replicate exercise's biochemical effects, has successfully completed …
Bias & Framing
⚖
Article uses catastrophic framing and WHO warnings to emphasize Ebola severity, though factual reporting is undermined by sensationalized headline and selective emphasis on worst-case scenarios.
Bias Direction
center-right
Confidence
MED
Crisis amplification through superlatives ('deadliest ever,' 'moving faster') and WHO authority citations; headline emphasizes worst-case trajectory rather than current status or containment efforts
set to be 'deadliest ever'
rare strand
dangerous strand
rapidly spread
significantly more difficult to contain
virus is ahead of us
Local DRC health officials' assessments and response strategies
Epidemiologists discussing containment success rates or comparative outbreak trajectories
Community perspectives from affected regions
Vaccine development timeline or alternative treatment options
Historical context on previous outbreak predictions vs. actual outcomes
Economic/resource constraints affecting response efforts
Geopolitical Impact
🌎
Rare Bundibugyo Ebola strain in DRC threatens to become deadliest epidemic ever with 2,060+ deaths, no approved vaccine, and faster transmission than previous outbreaks.
Escalation Risk
critical
Confidence
HIGH
Democratic Republic of Congo
Uganda
Central Africa
Sub-Saharan Africa
WHO authority and international health governance tested; DRC's healthcare infrastructure overwhelmed; potential shift in global health priorities toward neglected tropical diseases; African nations' vulnerability exposed, increasing dependence on international aid and coordination.
2014-2016 West African Ebola epidemic (11,000+ deaths) which exposed gaps in global health security and triggered major reforms in pandemic preparedness frameworks.
Economic Lens
📈
Rare Bundibugyo Ebola strain in DRC kills 2,060+ with no approved vaccine, threatening to become deadliest epidemic ever with 45% fatality rate and rapid transmission.
Market Signal
bearish
Confidence
HIGH
Healthcare and pharmaceuticals
Medical devices and diagnostics
Travel and tourism
Agriculture and food production
Insurance and risk management
International development and aid
Consumers in affected regions face reduced access to healthcare services, increased medical costs, travel restrictions, and potential supply chain disruptions for goods and services. Global consumers may experience higher insurance premiums and pharmaceutical price increases.
Governments likely to increase emergency health spending, accelerate vaccine development funding, implement travel restrictions, strengthen border health screening, and coordinate international aid. Potential for WHO emergency declarations triggering trade and movement protocols.